NCT01423643View on ClinicalTrials.gov

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

CompletedOBSERVATIONAL
Enrollment

1,250

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
HIV InfectionHepatitis C
Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT01423643 - HCV/HIV Coinfection: Antiviral Therapy and Fibrosis | Biotech Hunter | Biotech Hunter